- Home
- PRAX vs IDT Comparison
PRAX vs IDT Comparison
Compare PRAX & IDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- IDT
- Stock Information
- Founded
- PRAX 2015
- IDT 1990
- Country
- PRAX United States
- IDT United States
- Employees
- PRAX N/A
- IDT N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- IDT Telecommunications Equipment
- Sector
- PRAX Health Care
- IDT Telecommunications
- Exchange
- PRAX Nasdaq
- IDT Nasdaq
- Market Cap
- PRAX 1.4B
- IDT 1.2B
- IPO Year
- PRAX 2020
- IDT 1996
- Fundamental
- Price
- PRAX $74.49
- IDT $48.64
- Analyst Decision
- PRAX Strong Buy
- IDT
- Analyst Count
- PRAX 9
- IDT 0
- Target Price
- PRAX $149.00
- IDT N/A
- AVG Volume (30 Days)
- PRAX 388.8K
- IDT 52.0K
- Earning Date
- PRAX 03-04-2025
- IDT 03-05-2025
- Dividend Yield
- PRAX N/A
- IDT 0.41%
- EPS Growth
- PRAX N/A
- IDT 101.16
- EPS
- PRAX N/A
- IDT 2.92
- Revenue
- PRAX $1,605,000.00
- IDT $1,214,139,000.00
- Revenue This Year
- PRAX N/A
- IDT N/A
- Revenue Next Year
- PRAX N/A
- IDT N/A
- P/E Ratio
- PRAX N/A
- IDT $16.66
- Revenue Growth
- PRAX N/A
- IDT N/A
- 52 Week Low
- PRAX $33.01
- IDT $33.84
- 52 Week High
- PRAX $91.83
- IDT $58.77
- Technical
- Relative Strength Index (RSI)
- PRAX 42.80
- IDT 54.22
- Support Level
- PRAX $76.00
- IDT $48.45
- Resistance Level
- PRAX $91.83
- IDT $49.00
- Average True Range (ATR)
- PRAX 6.29
- IDT 0.85
- MACD
- PRAX -1.10
- IDT 0.16
- Stochastic Oscillator
- PRAX 2.42
- IDT 61.38
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.
About IDT IDT Corporation Class B
IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.